Will AbbVie’s $10.9 Billion Acquisition Shape Its Dividend?
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Knowing when to start retirement discussions with a financial advisor can enhance your planning. Get the guidance you need to succeed.
20,658 articlesAbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
When a major AI breach hit, Hugging Face found a fast, practical path by running a Chinese model locally. This decisi...
A veteran journalist outlines Elliott Investment Management’s influence on Norwegian Cruise Line amid a strong cruise...
A rising institutional move shines a light on how large managers deploy capital in broad market ETFs. This piece brea...
A sharp rally in tandem diabetes care stock followed a profitability upgrade, signaling a shift from revenue-only gro...
When a big investor exits a biotech stock, it rattles the market and raises questions. This deep dive explains the 'f...
New data released this week shows Americans facing persistent affordability pressures. Three charts highlight afforda...
Steve Madden Ltd. will not provide earnings guidance for the upcoming quarter after a Supreme Court tariff ruling inj...
With the 2026 midterms approaching, crypto markets face shifting liquidity and policy bets that could drive a notable...
Analysts are warming to a pair of fintech names as valuations cool and growth metrics improve. This report explains w...
FMC Corporation has faced headwinds that can derail even strong portfolios. Here are two words that should make inves...
GitLab posted its Q4 FY2026 results after the bell, showing revenue and earnings that set the stage for 2027. Stocks ...